Prakash Gudsoorkar
@gudnephron.bsky.social
910 followers 620 following 1.2K posts
Asso Prof UCCOM I Kidneydoc | @UCKidney Lead, OncoNeph Program ❤️ Onconeph, 🏡 dialysis, ICU Neph Deputy Editor @KidneyNews Editorial Board @akdhjounal @BMCNephro ⭐️wars 🤓 Fav 🏞️ : Grand Tetons 🐶🐾🦴 Dad 🇮🇳 ~> 🇨🇦 ~> 🇺🇸
Posts Media Videos Starter Packs
Reposted by Prakash Gudsoorkar
This #ASNKidneyNews special section on green nephrology brings together insights from experts advocating responsible innovation in kidney care, balancing clinical efficacy with ecological stewardship. Explore the articles: bit.ly/KN-Green
@gudnephron.bsky.social
Reposted by Prakash Gudsoorkar
Oral health is often overlooked in nephrology care, despite significant implications. Authors unveil the crosstalk between oral and kidney health. bit.ly/KN1703-18
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews
Reposted by Prakash Gudsoorkar
What are some of the common and rare indications and complications of therapeutic plasma exchange? Find out in our new study published in BMC Nephrology! 🩸https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-03970-2#citeas

@gudnephron.bsky.social

#NephSky #MedStudentSky
Reposted by Prakash Gudsoorkar
Reposted by Prakash Gudsoorkar
even the @theisn.org #ISNWCN has two high impact trial sessions!

This has to be one of the #TopNephrology stories

the era of nephrology lagging behind in RCTs is over

#NephSky
Reposted by Prakash Gudsoorkar
RBC cast - brightfield with SM stain - from patient admitted with AKI, "pneumonia" and fatigue - serologies all negative - biopsy pending ... #UrineMicroscopy #UrinarySediment
Reposted by Prakash Gudsoorkar
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:
Reposted by Prakash Gudsoorkar
I am at the beginning of my AI journey of discovery, you know the place where you are still dumbfounded by what the machine can do. In this case it developed a pretty compelling electrolyte curriculum for nephrology fellows 😳

pbfluids.com/2024/11/ai-c...
AI Curriculum
I am still in the “amazed by what AI can do” stage Here is me prompt i am teaching a class on electrolyte abnormalities for nephrologists. What would be good tricky things to teach I th…
pbfluids.com
Reposted by Prakash Gudsoorkar
JAMA @jama.com · Nov 17
FINEARTS-HF trial in JAMA Cardiology:

Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24

https://ja.ma/4euKMwg
Reposted by Prakash Gudsoorkar
Transition from an estimated glomerular filtration rate (eGFR)-based to a risk-based approach to CKD care from KDIGO
#Nephpearls #NephSky

👉 kdigo.org/guidelines/c...

💻 kidneyfailurerisk.com
Reposted by Prakash Gudsoorkar
#NPS
Grand Tetons in the backdrop
Bear lake hike
Reposted by Prakash Gudsoorkar